로딩 중…
지수 로딩 중…
Humacyte, Inc.
HUMA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$0.91-5.65%
2026-06-18
Price Chart
Humacyte, Inc.-61.26%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $203M |
| Revenue | $2M |
| Net Income | $-98M |
| Total Assets | $111M |
| Net Assets | $12M |
| Value | |
| P/B | 17.46x |
| P/S | 100.68x |
| FCF Yield | -50.44% |
| Profitability | |
| ROA | -88.27% |
| Op. Margin | -5649.21% |
| Revenue Growth | -4.26% |
| Earnings Growth | -145.02% |
| Financial Health | |
| Debt Ratio | 851.11% |
| Total Debt | $66M |
| FCF | $-102M |
| Cash | $49M |
| Current Ratio | 3.93x |
| Performance | |
| 1Y Return | -61.26% |
| 1M Return | 10.77% |
| From 52W High | -67.81% |
| 1Y MDD | -79.26% |
| Trading | |
| Volume | 9,607,737 shares |
| Trading Value | $9M |
| Per Share | |
| EPS | $-0.10 |